AUS
NZ
UK
CA
USA
IND
Healthcare
Is Sonic Healthcare (ASX:SHL) Undervalued Or Are Margin Pressures Still A Key Risk?
July 08, 2026 10:59 AM AEST| By SamSonic Healthcare remains under close market observation as valuation discussions continue alongside ongoing margin pressures, operational improvements and long-term demand for global diagnostic healthcare services.
Is Clarity Pharmaceuticals (ASX:CU6) Redefining Cancer Treatment Through Its Copper Theranostics Platform?
July 08, 2026 10:55 AM AEST| By SamClarity Pharmaceuticals continues advancing its copper theranostics platform through multiple oncology programs while upcoming clinical milestones remain central to its long-term biotechnology development strategy.
What Does ResMed's (ASX:RMD) MatrixCare Sale Mean for Its Future Growth Strategy?
July 08, 2026 09:51 AM AEST| By SamResMed is streamlining its healthcare portfolio through the MatrixCare divestment while strengthening its focus on sleep health, respiratory care, connected care and long-term operational execution.
Top CSL (ASX:CSL) Comeback: What's Really Fueling the Healthcare Rally?
July 07, 2026 10:19 PM AEST| By SamAustralia's healthcare sector has staged a broad recovery led by CSL, with Pro Medicus, ResMed and other major healthcare businesses regaining momentum as markets await upcoming earnings updates to assess the strength of the rebound.
Can Medicus (ASX:PME) Sustain Momentum After Analyst Price Target Cuts?
July 07, 2026 10:17 PM AEST| By SamPro Medicus strengthened its US presence through a major contract renewal while continuing to deliver solid financial growth. Although market valuation expectations have moderated, the company's healthcare technology business continues demonstrating...
Why Is CSL (ASX:CSL) Leading the Pharmacy Reset Across Healthcare Stocks?
July 07, 2026 08:45 PM AEST| By SamHealthcare stocks are attracting renewed attention as pharmacy and diagnostics trends reshape market focus, with CSL, ResMed, Pro Medicus and Sigma Healthcare highlighting changing sector dynamics across Australia.
Argent BioPharma Licensing Deal Strengthens Global Growth Strategy
July 07, 2026 03:54 PM AEST| By SamArgent BioPharma advances its global strategy through a licensing agreement that strengthens its balance sheet, retains intellectual property ownership, and expands long-term commercial opportunities.
Why Are CSL (ASX:CSL) Healthcare Stocks In Focus?
July 07, 2026 03:13 PM AEST| By SamASX healthcare stocks are being assessed through recovery proof, medical software validation and company-specific signals across CSL, ResMed, Pro Medicus and Sigma Healthcare.
Why Are CSL (ASX:CSL) Healthcare Stocks Back In Focus?
July 07, 2026 11:52 AM AEST| By SamASX healthcare stocks are being assessed through recovery proof, medical software validation and company-specific signals across CSL, ResMed, Pro Medicus and Sigma Healthcare.
Why Is Cochlear (ASX:COH) Back in Focus as Healthcare Activity Improves?
July 07, 2026 11:07 AM AEST| By SamCochlear continues attracting attention as healthcare activity improves, supporting renewed focus on hearing implant demand, operational execution and Australia's globally recognised medical technology industry.
Why Is EchoIQ (ASX:EIQ) Quoting New Shares on the ASX?
July 07, 2026 10:52 AM AEST| By SamEchoIQ has applied to quote newly issued ordinary shares on the ASX, expanding its listed security base while supporting capital management and regulatory compliance.
Top Healthcare Stocks to Watch: Why Pro (ASX:PME) Is Leading a New Market Conversation
July 06, 2026 09:45 PM AEST| By SamHealthcare stocks are attracting renewed attention as markets increasingly prioritise workflow efficiency, recurring revenue and hospital technology adoption, with Pro Medicus, ResMed, Neuren Pharmaceuticals and Sonic Healthcare illustrating the sect...
Why Is CSL (ASX:CSL) Leading the Healthcare Revival on the ASX?
July 06, 2026 04:46 PM AEST| By SamCSL has returned to the spotlight as healthcare stocks regain momentum, with sector-wide rotation, global healthcare exposure and upcoming operational updates shaping attention across Australia's leading healthcare companies.
Why Is Pro Medicus (ASX:PME) Driving the ASX Healthcare Revival?
July 06, 2026 01:23 PM AEST| By SamPro Medicus strengthened its market position through new US healthcare contracts and the Echo IQ partnership as renewed momentum across Australia's healthcare sector continues supporting commercial technology leaders.
Is 4DMedical (ASX:4DX) Still Undervalued After Its TGA Approval?
July 06, 2026 10:29 AM AEST| By Sam4DMedical has strengthened its commercial outlook through TGA approval for its CT:VQ imaging software, highlighting growing innovation across artificial intelligence, digital diagnostics and Australia's healthcare technology industry.
Why Is CSL (ASX:CSL) Driving the ASX 200 Healthcare Revival?
July 06, 2026 03:55 AM AEST| By SamHealthcare shares have regained market leadership as CSL, Pro Medicus, Telix Pharmaceuticals and other leading companies drive a broad sector recovery supported by improving sentiment and resilient business fundamentals.
Is Sonic Healthcare's Valuation Telling a Different Story in 2026?
July 04, 2026 07:00 PM AEST| By SamSonic Healthcare's valuation has returned to focus as markets assess revenue resilience, profitability and long-term healthcare demand, highlighting the importance of diversified diagnostics businesses across international healthcare markets.
Why Is Pro Medicus (ASX:PME) Dominating Medical Imaging Software?
July 03, 2026 06:42 PM AEST| By SamPro Medicus continues expanding its medical imaging software business through growing hospital adoption, reinforcing its position as one of Australia's leading healthcare technology companies.
Why Healthcare Stocks Are Back In Focus As Rebound Quality Test Takes Over
July 03, 2026 06:27 PM AEST| By SamAustralia's healthcare sector is back in focus as markets increasingly reward earnings quality, resilient business models and disciplined execution, with CSL, ResMed, Pro Medicus and Cochlear highlighting the sector's evolving leadership.
Top Healthcare Stocks to Watch: Sonic Healthcare (ASX:SHL) Leads the Defensive Shift
July 03, 2026 06:26 PM AEST| By SamAustralia's healthcare sector is drawing renewed attention as diagnostics, hospitals, insurers and medical technology companies are increasingly assessed on resilient earnings, financial discipline and operational quality within a more selective mark...
Advertise your brand on Kalkine Media